The OncoSign brand, founded in 2005 (Germany), from 14 sister brands. The OncoSign brand is owned by Epigenomics, a company listed in Francfort. The International Securities Identification Number (ISIN) of Epigenomics is DE000A11QW50. The sector of OncoSign is Divers.